Drew Weissman, a pioneer in mRNA technology, shares the 2023 Nobel Prize in Physiology or Medicine for revolutionizing vaccine development

Who is Drew Weissman?

Drew Weissman, a trailblazer in the world of mRNA technology, has been awarded the prestigious 2023 Nobel Prize in Physiology or Medicine for his groundbreaking contributions that have reshaped the landscape of vaccine development. Weissman’s work, in collaboration with Katalin Karikó, has not only accelerated the creation of COVID-19 vaccines but holds immense promise for future medical advancements.

Also read | Amazon Quiz: Which former chair of the US Federal Reserve … 2022 Nobel Prize in economic sciences?

The Nobel Prize website aptly describes their work as having “fundamentally changed our understanding of how mRNA interacts with our immune system.” This transformative research played a pivotal role in the rapid development of vaccines during one of the most significant health crises in recent history.

Traditionally, vaccines relied on introducing weakened or inactivated viruses into the body to stimulate an immune response. However, this method required extensive cell culture and time-consuming processes. When COVID-19 emerged as a deadly and rapidly spreading threat, time became an invaluable commodity.

This is where mRNA technology, a concept dating back to the 1980s but previously unsuitable for large-scale vaccine production, stepped in. Instead of introducing a virus into the body, mRNA vaccines use messenger Ribonucleic Acid (mRNA) to deliver instructions to the immune system. Genetically engineered mRNA instructs cells to produce specific proteins needed to combat a particular virus, eliminating the need for cell culture.

Also read | Amazon Quiz: Cooking to Save Your Life’ Is a collection of recipes from which Nobel Prize winner?

Weissman and Karikó’s pivotal realization was that the body’s dendritic cells recognized these genetically engineered mRNAs as foreign substances, leading to an inflammatory response. To address this issue, they introduced chemical alterations in the mRNA bases, resulting in a significant reduction in inflammatory reactions. These groundbreaking findings, published in 2005, set the stage for the development of mRNA vaccines.

Moderna and Pfizer’s COVID-19 vaccines, both utilizing this mRNA technology, emerged as front-runners in the race for an effective solution. Weissman and Karikó’s dedication and innovative spirit paved the way for these vaccines that have saved countless lives worldwide.

Before receiving the Nobel Prize, Drew Weissman, born in 1959 in Lexington, Massachusetts, pursued extensive academic and research endeavors, culminating in his establishment as the Roberts Family Professor in Vaccine Research and Director of the Penn Institute for RNA Innovations at the Perelman School of Medicine, University of Pennsylvania.

Weissman’s contributions to science and medicine will continue to resonate, underscoring the profound impact of mRNA technology on vaccine development and offering hope for tackling future health challenges.